Looking Ahead: The Key Takeaways

The panel closes with forward-looking perspectives on where the field is heading analytically, scientifically, and regulatorily over the next three to five years. Each panelist shares their view on the developments most likely to shape the landscape, from anticipated changes in acceptable limits and testing requirements through to the evolution of expertise within the industry and the broader implications of progress in this field for other areas of impurity management. The segment balances optimism about the direction of travel with a realistic assessment of the work still to be done, and offers a fitting conclusion to a wide-ranging discussion that has spanned the full life cycle of nitrosamine risk management.

Moderated by Joseph Lackey, Technical Manager at LGC Standards, the discussion brings together Jason Brown, Principal Consultant at Brown Pharma Consulting Ltd, Maria Kristina Parr, a professor in pharmaceutical chemistry from the Freie Universität Berlin, Jörg Schlingemann, Director, Principal Expert Quality Control Systems at Merck Healthcare KGaA, and George Johnson, an associate professor at Swansea University.